Reports

Industry Research Reports

Global Hemocompatibility Testing Service Market Research Report 2026

Global Hemocompatibility Testing Service Market Research Report 2026

Industry: Service & Software

Published Date: 2026-03-09

Pages: 129 Pages

Report ld: 6079550

application for samples

Request Sample

Custom reports

Customized Report

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

Hemocompatibility Testing Service Market Size(US$)

den_QYR1
cagr

CAGR 2026-2032

7.3%

marketSize

Market Size,2032

USD 148

Million

Market Snapshot

Market Size in 2026 (Value)
US$ 97 million
Market Forecast in 2032(Value)
US$ 148 million
CAGR
7.3%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Hemocompatibility Testing Service market was valued at US$ 91 million in 2025 and is anticipated to reach US$ 148 million by 2032, at a CAGR of 7.3% from 2026 to 2032.

Hemocompatibility testing service refers to a specialized analytical evaluation conducted to assess how biological materials, medical devices, or pharmaceuticals interact with blood components, ensuring they do not trigger adverse reactions such as thrombosis, hemolysis, inflammation, or immune responses. This service involves in vitro (test tube) and sometimes in vivo (animal model) assessments to measure parameters like blood cell adhesion, platelet activation, complement system activation, and coagulation factor disruption. It is crucial for the development and regulatory approval of medical products such as implants, catheters, artificial organs, or drug delivery systems, as non-hemocompatible materials can lead to life-threatening complications in patients. By simulating physiological conditions, these tests help manufacturers and researchers validate the safety of materials before human use, ensuring they integrate with the body’s circulatory system without compromising blood integrity or function.

The North American market for Hemocompatibility Testing Service is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Hemocompatibility Testing Service is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The global market for Hemocompatibility Testing Service in Medical Device Development is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.

Major global companies of Hemocompatibility Testing Service include Matexcel, Eurofins, Nelson Laboratories, LLC, Haemoscan, Measurlabs, STEMart, NAMSA, Lupine Medical, Eurolab, Nucro-Technics, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Hemocompatibility Testing Service market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Hemocompatibility Testing Service. The Hemocompatibility Testing Service market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Hemocompatibility Testing Service market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Hemocompatibility Testing Service manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

MARKET SEGMENTATION

By Company

  • Matexcel
  • Eurofins
  • Nelson Laboratories, LLC
  • Haemoscan
  • Measurlabs
  • STEMart
  • NAMSA
  • Lupine Medical
  • Eurolab
  • Nucro-Technics
  • TÜV SÜD
  • Eucerep
  • UL Solutions
  • Level Biotechnology Inc.
  • Cosmos Biomed Consulting
  • Charles River Laboratories
  • Ceshigo
  • Kerbio
  • Weike Inspection Group
  • CTI

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • Hemolysis Testing
  • Complement Activation Testing
  • Platelet Activation Testing
  • Thrombogenicity Testing
  • Coagulation Testing
  • Others

Segment by Application

  • Medical Device Development
  • Biomedical Materials Research
  • Others

biaoTi CHAPTER OUTLINE

marn_i1

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.

marn_i1

Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.

marn_i1

Chapter 3: Provides a detailed view of the competitive landscape for Hemocompatibility Testing Service companies, covering revenue share, development plans, and mergers and acquisitions.

marn_i1

Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.

marn_i1

Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

marn_i1

Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.

marn_i1

Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.

marn_i1

Chapter 12: Key findings and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

TABLE OF CONTENTS

muLu

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Hemocompatibility Testing Service Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Hemolysis Testing

1.2.3 Complement Activation Testing

1.2.4 Platelet Activation Testing

1.2.5 Thrombogenicity Testing

1.2.6 Coagulation Testing

1.2.7 Others

1.3 Market by Application

1.3.1 Global Hemocompatibility Testing Service Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Medical Device Development

1.3.3 Biomedical Materials Research

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

muLu

2 Global Growth Trends

2.1 Global Hemocompatibility Testing Service Market Perspective (2021–2032)

2.2 Global Hemocompatibility Testing Service Growth Trends by Region

2.2.1 Global Hemocompatibility Testing Service Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Hemocompatibility Testing Service Historic Market Size by Region (2021–2026)

2.2.3 Hemocompatibility Testing Service Forecasted Market Size by Region (2027–2032)

2.3 Hemocompatibility Testing Service Market Dynamics

2.3.1 Hemocompatibility Testing Service Industry Trends

2.3.2 Hemocompatibility Testing Service Market Drivers

2.3.3 Hemocompatibility Testing Service Market Challenges

2.3.4 Hemocompatibility Testing Service Market Restraints

muLu

3 Competition Landscape by Key Players

3.1 Global Top Hemocompatibility Testing Service Players by Revenue

3.1.1 Global Top Hemocompatibility Testing Service Players by Revenue (2021–2026)

3.1.2 Global Hemocompatibility Testing Service Revenue Market Share by Players (2021–2026)

3.2 Global Top Hemocompatibility Testing Service Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Hemocompatibility Testing Service Revenue

3.4 Global Hemocompatibility Testing Service Market Concentration Ratio

3.4.1 Global Hemocompatibility Testing Service Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Hemocompatibility Testing Service Revenue in 2025

3.5 Global Key Players of Hemocompatibility Testing Service Head Offices and Areas Served

3.6 Global Key Players of Hemocompatibility Testing Service, Products and Applications

3.7 Global Key Players of Hemocompatibility Testing Service, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

muLu

4 Hemocompatibility Testing Service Breakdown Data by Type

4.1 Global Hemocompatibility Testing Service Historic Market Size by Type (2021–2026)

4.2 Global Hemocompatibility Testing Service Forecasted Market Size by Type (2027–2032)

muLu

5 Hemocompatibility Testing Service Breakdown Data by Application

5.1 Global Hemocompatibility Testing Service Historic Market Size by Application (2021–2026)

5.2 Global Hemocompatibility Testing Service Forecasted Market Size by Application (2027–2032)

muLu

6 North America

6.1 North America Hemocompatibility Testing Service Market Size (2021–2032)

6.2 North America Hemocompatibility Testing Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Hemocompatibility Testing Service Market Size by Country (2021–2026)

6.4 North America Hemocompatibility Testing Service Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

muLu

7 Europe

7.1 Europe Hemocompatibility Testing Service Market Size (2021–2032)

7.2 Europe Hemocompatibility Testing Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Hemocompatibility Testing Service Market Size by Country (2021–2026)

7.4 Europe Hemocompatibility Testing Service Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

muLu

8 Asia-Pacific

8.1 Asia-Pacific Hemocompatibility Testing Service Market Size (2021–2032)

8.2 Asia-Pacific Hemocompatibility Testing Service Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Hemocompatibility Testing Service Market Size by Region (2021–2026)

8.4 Asia-Pacific Hemocompatibility Testing Service Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

muLu

9 Latin America

9.1 Latin America Hemocompatibility Testing Service Market Size (2021–2032)

9.2 Latin America Hemocompatibility Testing Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Hemocompatibility Testing Service Market Size by Country (2021–2026)

9.4 Latin America Hemocompatibility Testing Service Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

muLu

10 Middle East & Africa

10.1 Middle East & Africa Hemocompatibility Testing Service Market Size (2021–2032)

10.2 Middle East & Africa Hemocompatibility Testing Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Hemocompatibility Testing Service Market Size by Country (2021–2026)

10.4 Middle East & Africa Hemocompatibility Testing Service Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

muLu

11 Key Players Profiles

11.1 Matexcel

11.1.1 Matexcel Company Details

11.1.2 Matexcel Business Overview

11.1.3 Matexcel Hemocompatibility Testing Service Introduction

11.1.4 Matexcel Revenue in Hemocompatibility Testing Service Business (2021–2026)

11.1.5 Matexcel Recent Development

11.2 Eurofins

11.2.1 Eurofins Company Details

11.2.2 Eurofins Business Overview

11.2.3 Eurofins Hemocompatibility Testing Service Introduction

11.2.4 Eurofins Revenue in Hemocompatibility Testing Service Business (2021–2026)

11.2.5 Eurofins Recent Development

11.3 Nelson Laboratories, LLC

11.3.1 Nelson Laboratories, LLC Company Details

11.3.2 Nelson Laboratories, LLC Business Overview

11.3.3 Nelson Laboratories, LLC Hemocompatibility Testing Service Introduction

11.3.4 Nelson Laboratories, LLC Revenue in Hemocompatibility Testing Service Business (2021–2026)

11.3.5 Nelson Laboratories, LLC Recent Development

11.4 Haemoscan

11.4.1 Haemoscan Company Details

11.4.2 Haemoscan Business Overview

11.4.3 Haemoscan Hemocompatibility Testing Service Introduction

11.4.4 Haemoscan Revenue in Hemocompatibility Testing Service Business (2021–2026)

11.4.5 Haemoscan Recent Development

11.5 Measurlabs

11.5.1 Measurlabs Company Details

11.5.2 Measurlabs Business Overview

11.5.3 Measurlabs Hemocompatibility Testing Service Introduction

11.5.4 Measurlabs Revenue in Hemocompatibility Testing Service Business (2021–2026)

11.5.5 Measurlabs Recent Development

11.6 STEMart

11.6.1 STEMart Company Details

11.6.2 STEMart Business Overview

11.6.3 STEMart Hemocompatibility Testing Service Introduction

11.6.4 STEMart Revenue in Hemocompatibility Testing Service Business (2021–2026)

11.6.5 STEMart Recent Development

11.7 NAMSA

11.7.1 NAMSA Company Details

11.7.2 NAMSA Business Overview

11.7.3 NAMSA Hemocompatibility Testing Service Introduction

11.7.4 NAMSA Revenue in Hemocompatibility Testing Service Business (2021–2026)

11.7.5 NAMSA Recent Development

11.8 Lupine Medical

11.8.1 Lupine Medical Company Details

11.8.2 Lupine Medical Business Overview

11.8.3 Lupine Medical Hemocompatibility Testing Service Introduction

11.8.4 Lupine Medical Revenue in Hemocompatibility Testing Service Business (2021–2026)

11.8.5 Lupine Medical Recent Development

11.9 Eurolab

11.9.1 Eurolab Company Details

11.9.2 Eurolab Business Overview

11.9.3 Eurolab Hemocompatibility Testing Service Introduction

11.9.4 Eurolab Revenue in Hemocompatibility Testing Service Business (2021–2026)

11.9.5 Eurolab Recent Development

11.10 Nucro-Technics

11.10.1 Nucro-Technics Company Details

11.10.2 Nucro-Technics Business Overview

11.10.3 Nucro-Technics Hemocompatibility Testing Service Introduction

11.10.4 Nucro-Technics Revenue in Hemocompatibility Testing Service Business (2021–2026)

11.10.5 Nucro-Technics Recent Development

11.11 TÜV SÜD

11.11.1 TÜV SÜD Company Details

11.11.2 TÜV SÜD Business Overview

11.11.3 TÜV SÜD Hemocompatibility Testing Service Introduction

11.11.4 TÜV SÜD Revenue in Hemocompatibility Testing Service Business (2021–2026)

11.11.5 TÜV SÜD Recent Development

11.12 Eucerep

11.12.1 Eucerep Company Details

11.12.2 Eucerep Business Overview

11.12.3 Eucerep Hemocompatibility Testing Service Introduction

11.12.4 Eucerep Revenue in Hemocompatibility Testing Service Business (2021–2026)

11.12.5 Eucerep Recent Development

11.13 UL Solutions

11.13.1 UL Solutions Company Details

11.13.2 UL Solutions Business Overview

11.13.3 UL Solutions Hemocompatibility Testing Service Introduction

11.13.4 UL Solutions Revenue in Hemocompatibility Testing Service Business (2021–2026)

11.13.5 UL Solutions Recent Development

11.14 Level Biotechnology Inc.

11.14.1 Level Biotechnology Inc. Company Details

11.14.2 Level Biotechnology Inc. Business Overview

11.14.3 Level Biotechnology Inc. Hemocompatibility Testing Service Introduction

11.14.4 Level Biotechnology Inc. Revenue in Hemocompatibility Testing Service Business (2021–2026)

11.14.5 Level Biotechnology Inc. Recent Development

11.15 Cosmos Biomed Consulting

11.15.1 Cosmos Biomed Consulting Company Details

11.15.2 Cosmos Biomed Consulting Business Overview

11.15.3 Cosmos Biomed Consulting Hemocompatibility Testing Service Introduction

11.15.4 Cosmos Biomed Consulting Revenue in Hemocompatibility Testing Service Business (2021–2026)

11.15.5 Cosmos Biomed Consulting Recent Development

11.16 Charles River Laboratories

11.16.1 Charles River Laboratories Company Details

11.16.2 Charles River Laboratories Business Overview

11.16.3 Charles River Laboratories Hemocompatibility Testing Service Introduction

11.16.4 Charles River Laboratories Revenue in Hemocompatibility Testing Service Business (2021–2026)

11.16.5 Charles River Laboratories Recent Development

11.17 Ceshigo

11.17.1 Ceshigo Company Details

11.17.2 Ceshigo Business Overview

11.17.3 Ceshigo Hemocompatibility Testing Service Introduction

11.17.4 Ceshigo Revenue in Hemocompatibility Testing Service Business (2021–2026)

11.17.5 Ceshigo Recent Development

11.18 Kerbio

11.18.1 Kerbio Company Details

11.18.2 Kerbio Business Overview

11.18.3 Kerbio Hemocompatibility Testing Service Introduction

11.18.4 Kerbio Revenue in Hemocompatibility Testing Service Business (2021–2026)

11.18.5 Kerbio Recent Development

11.19 Weike Inspection Group

11.19.1 Weike Inspection Group Company Details

11.19.2 Weike Inspection Group Business Overview

11.19.3 Weike Inspection Group Hemocompatibility Testing Service Introduction

11.19.4 Weike Inspection Group Revenue in Hemocompatibility Testing Service Business (2021–2026)

11.19.5 Weike Inspection Group Recent Development

11.20 CTI

11.20.1 CTI Company Details

11.20.2 CTI Business Overview

11.20.3 CTI Hemocompatibility Testing Service Introduction

11.20.4 CTI Revenue in Hemocompatibility Testing Service Business (2021–2026)

11.20.5 CTI Recent Development

muLu

12 Analyst's Viewpoints/Conclusions

muLu

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

den_biaoTiZhungShi

TABLE OF FIGURES

muLu

List of Tables

Table 1. Global Hemocompatibility Testing Service Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Hemolysis Testing
Table 3. Key Players of Complement Activation Testing
Table 4. Key Players of Platelet Activation Testing
Table 5. Key Players of Thrombogenicity Testing
Table 6. Key Players of Coagulation Testing
Table 7. Key Players of Others
Table 8. Global Hemocompatibility Testing Service Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 9. Global Hemocompatibility Testing Service Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 10. Global Hemocompatibility Testing Service Market Size by Region (US$ Million), 2021–2026
Table 11. Global Hemocompatibility Testing Service Market Share by Region (2021–2026)
Table 12. Global Hemocompatibility Testing Service Forecasted Market Size by Region (US$ Million), 2027–2032
Table 13. Global Hemocompatibility Testing Service Market Share by Region (2027–2032)
Table 14. Hemocompatibility Testing Service Market Trends
Table 15. Hemocompatibility Testing Service Market Drivers
Table 16. Hemocompatibility Testing Service Market Challenges
Table 17. Hemocompatibility Testing Service Market Restraints
Table 18. Global Hemocompatibility Testing Service Revenue by Players (US$ Million), 2021–2026
Table 19. Global Hemocompatibility Testing Service Market Share by Players (2021–2026)
Table 20. Global Top Hemocompatibility Testing Service Players by Tier (Tier 1, Tier 2, and Tier 3), based on Hemocompatibility Testing Service Revenue, 2025
Table 21. Ranking of Global Top Hemocompatibility Testing Service Companies by Revenue (US$ Million) in 2025
Table 22. Global 5 Largest Players Market Share by Hemocompatibility Testing Service Revenue (CR5 and HHI), 2021–2026
Table 23. Global Key Players of Hemocompatibility Testing Service, Headquarters and Area Served
Table 24. Global Key Players of Hemocompatibility Testing Service, Products and Applications
Table 25. Global Key Players of Hemocompatibility Testing Service, Date of General Availability (GA)
Table 26. Mergers and Acquisitions, Expansion Plans
Table 27. Global Hemocompatibility Testing Service Market Size by Type (US$ Million), 2021–2026
Table 28. Global Hemocompatibility Testing Service Revenue Market Share by Type (2021–2026)
Table 29. Global Hemocompatibility Testing Service Forecasted Market Size by Type (US$ Million), 2027–2032
Table 30. Global Hemocompatibility Testing Service Revenue Market Share by Type (2027–2032)
Table 31. Global Hemocompatibility Testing Service Market Size by Application (US$ Million), 2021–2026
Table 32. Global Hemocompatibility Testing Service Revenue Market Share by Application (2021–2026)
Table 33. Global Hemocompatibility Testing Service Forecasted Market Size by Application (US$ Million), 2027–2032
Table 34. Global Hemocompatibility Testing Service Revenue Market Share by Application (2027–2032)
Table 35. North America Hemocompatibility Testing Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. North America Hemocompatibility Testing Service Market Size by Country (US$ Million), 2021–2026
Table 37. North America Hemocompatibility Testing Service Market Size by Country (US$ Million), 2027–2032
Table 38. Europe Hemocompatibility Testing Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 39. Europe Hemocompatibility Testing Service Market Size by Country (US$ Million), 2021–2026
Table 40. Europe Hemocompatibility Testing Service Market Size by Country (US$ Million), 2027–2032
Table 41. Asia-Pacific Hemocompatibility Testing Service Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 42. Asia-Pacific Hemocompatibility Testing Service Market Size by Region (US$ Million), 2021–2026
Table 43. Asia-Pacific Hemocompatibility Testing Service Market Size by Region (US$ Million), 2027–2032
Table 44. Latin America Hemocompatibility Testing Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Latin America Hemocompatibility Testing Service Market Size by Country (US$ Million), 2021–2026
Table 46. Latin America Hemocompatibility Testing Service Market Size by Country (US$ Million), 2027–2032
Table 47. Middle East & Africa Hemocompatibility Testing Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 48. Middle East & Africa Hemocompatibility Testing Service Market Size by Country (US$ Million), 2021–2026
Table 49. Middle East & Africa Hemocompatibility Testing Service Market Size by Country (US$ Million), 2027–2032
Table 50. Matexcel Company Details
Table 51. Matexcel Business Overview
Table 52. Matexcel Hemocompatibility Testing Service Product
Table 53. Matexcel Revenue in Hemocompatibility Testing Service Business (US$ Million), 2021–2026
Table 54. Matexcel Recent Development
Table 55. Eurofins Company Details
Table 56. Eurofins Business Overview
Table 57. Eurofins Hemocompatibility Testing Service Product
Table 58. Eurofins Revenue in Hemocompatibility Testing Service Business (US$ Million), 2021–2026
Table 59. Eurofins Recent Development
Table 60. Nelson Laboratories, LLC Company Details
Table 61. Nelson Laboratories, LLC Business Overview
Table 62. Nelson Laboratories, LLC Hemocompatibility Testing Service Product
Table 63. Nelson Laboratories, LLC Revenue in Hemocompatibility Testing Service Business (US$ Million), 2021–2026
Table 64. Nelson Laboratories, LLC Recent Development
Table 65. Haemoscan Company Details
Table 66. Haemoscan Business Overview
Table 67. Haemoscan Hemocompatibility Testing Service Product
Table 68. Haemoscan Revenue in Hemocompatibility Testing Service Business (US$ Million), 2021–2026
Table 69. Haemoscan Recent Development
Table 70. Measurlabs Company Details
Table 71. Measurlabs Business Overview
Table 72. Measurlabs Hemocompatibility Testing Service Product
Table 73. Measurlabs Revenue in Hemocompatibility Testing Service Business (US$ Million), 2021–2026
Table 74. Measurlabs Recent Development
Table 75. STEMart Company Details
Table 76. STEMart Business Overview
Table 77. STEMart Hemocompatibility Testing Service Product
Table 78. STEMart Revenue in Hemocompatibility Testing Service Business (US$ Million), 2021–2026
Table 79. STEMart Recent Development
Table 80. NAMSA Company Details
Table 81. NAMSA Business Overview
Table 82. NAMSA Hemocompatibility Testing Service Product
Table 83. NAMSA Revenue in Hemocompatibility Testing Service Business (US$ Million), 2021–2026
Table 84. NAMSA Recent Development
Table 85. Lupine Medical Company Details
Table 86. Lupine Medical Business Overview
Table 87. Lupine Medical Hemocompatibility Testing Service Product
Table 88. Lupine Medical Revenue in Hemocompatibility Testing Service Business (US$ Million), 2021–2026
Table 89. Lupine Medical Recent Development
Table 90. Eurolab Company Details
Table 91. Eurolab Business Overview
Table 92. Eurolab Hemocompatibility Testing Service Product
Table 93. Eurolab Revenue in Hemocompatibility Testing Service Business (US$ Million), 2021–2026
Table 94. Eurolab Recent Development
Table 95. Nucro-Technics Company Details
Table 96. Nucro-Technics Business Overview
Table 97. Nucro-Technics Hemocompatibility Testing Service Product
Table 98. Nucro-Technics Revenue in Hemocompatibility Testing Service Business (US$ Million), 2021–2026
Table 99. Nucro-Technics Recent Development
Table 100. TÜV SÜD Company Details
Table 101. TÜV SÜD Business Overview
Table 102. TÜV SÜD Hemocompatibility Testing Service Product
Table 103. TÜV SÜD Revenue in Hemocompatibility Testing Service Business (US$ Million), 2021–2026
Table 104. TÜV SÜD Recent Development
Table 105. Eucerep Company Details
Table 106. Eucerep Business Overview
Table 107. Eucerep Hemocompatibility Testing Service Product
Table 108. Eucerep Revenue in Hemocompatibility Testing Service Business (US$ Million), 2021–2026
Table 109. Eucerep Recent Development
Table 110. UL Solutions Company Details
Table 111. UL Solutions Business Overview
Table 112. UL Solutions Hemocompatibility Testing Service Product
Table 113. UL Solutions Revenue in Hemocompatibility Testing Service Business (US$ Million), 2021–2026
Table 114. UL Solutions Recent Development
Table 115. Level Biotechnology Inc. Company Details
Table 116. Level Biotechnology Inc. Business Overview
Table 117. Level Biotechnology Inc. Hemocompatibility Testing Service Product
Table 118. Level Biotechnology Inc. Revenue in Hemocompatibility Testing Service Business (US$ Million), 2021–2026
Table 119. Level Biotechnology Inc. Recent Development
Table 120. Cosmos Biomed Consulting Company Details
Table 121. Cosmos Biomed Consulting Business Overview
Table 122. Cosmos Biomed Consulting Hemocompatibility Testing Service Product
Table 123. Cosmos Biomed Consulting Revenue in Hemocompatibility Testing Service Business (US$ Million), 2021–2026
Table 124. Cosmos Biomed Consulting Recent Development
Table 125. Charles River Laboratories Company Details
Table 126. Charles River Laboratories Business Overview
Table 127. Charles River Laboratories Hemocompatibility Testing Service Product
Table 128. Charles River Laboratories Revenue in Hemocompatibility Testing Service Business (US$ Million), 2021–2026
Table 129. Charles River Laboratories Recent Development
Table 130. Ceshigo Company Details
Table 131. Ceshigo Business Overview
Table 132. Ceshigo Hemocompatibility Testing Service Product
Table 133. Ceshigo Revenue in Hemocompatibility Testing Service Business (US$ Million), 2021–2026
Table 134. Ceshigo Recent Development
Table 135. Kerbio Company Details
Table 136. Kerbio Business Overview
Table 137. Kerbio Hemocompatibility Testing Service Product
Table 138. Kerbio Revenue in Hemocompatibility Testing Service Business (US$ Million), 2021–2026
Table 139. Kerbio Recent Development
Table 140. Weike Inspection Group Company Details
Table 141. Weike Inspection Group Business Overview
Table 142. Weike Inspection Group Hemocompatibility Testing Service Product
Table 143. Weike Inspection Group Revenue in Hemocompatibility Testing Service Business (US$ Million), 2021–2026
Table 144. Weike Inspection Group Recent Development
Table 145. CTI Company Details
Table 146. CTI Business Overview
Table 147. CTI Hemocompatibility Testing Service Product
Table 148. CTI Revenue in Hemocompatibility Testing Service Business (US$ Million), 2021–2026
Table 149. CTI Recent Development
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
Table 153. Authors List of This Report
muLu

List of Figures

Figure 1. Hemocompatibility Testing Service Picture
Figure 2. Global Hemocompatibility Testing Service Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Hemocompatibility Testing Service Market Share by Type: 2025 vs 2032
Figure 4. Hemolysis Testing Features
Figure 5. Complement Activation Testing Features
Figure 6. Platelet Activation Testing Features
Figure 7. Thrombogenicity Testing Features
Figure 8. Coagulation Testing Features
Figure 9. Others Features
Figure 10. Global Hemocompatibility Testing Service Market Size by Application (US$ Million), 2021–2032
Figure 11. Global Hemocompatibility Testing Service Market Share by Application: 2025 vs 2032
Figure 12. Medical Device Development Case Studies
Figure 13. Biomedical Materials Research Case Studies
Figure 14. Others Case Studies
Figure 15. Hemocompatibility Testing Service Report Years Considered
Figure 16. Global Hemocompatibility Testing Service Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 17. Global Hemocompatibility Testing Service Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 18. Global Hemocompatibility Testing Service Market Share by Region: 2025 vs 2032
Figure 19. Global Hemocompatibility Testing Service Market Share by Players in 2025
Figure 20. Global Hemocompatibility Testing Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. The Top 10 and 5 Players Market Share by Hemocompatibility Testing Service Revenue in 2025
Figure 22. North America Hemocompatibility Testing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. North America Hemocompatibility Testing Service Market Share by Country (2021–2032)
Figure 24. United States Hemocompatibility Testing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Canada Hemocompatibility Testing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Europe Hemocompatibility Testing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Europe Hemocompatibility Testing Service Market Share by Country (2021–2032)
Figure 28. Germany Hemocompatibility Testing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. France Hemocompatibility Testing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. U.K. Hemocompatibility Testing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Italy Hemocompatibility Testing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Russia Hemocompatibility Testing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Ireland Hemocompatibility Testing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Asia-Pacific Hemocompatibility Testing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Asia-Pacific Hemocompatibility Testing Service Market Share by Region (2021–2032)
Figure 36. China Hemocompatibility Testing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Japan Hemocompatibility Testing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. South Korea Hemocompatibility Testing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Southeast Asia Hemocompatibility Testing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. India Hemocompatibility Testing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Australia & New Zealand Hemocompatibility Testing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Latin America Hemocompatibility Testing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Latin America Hemocompatibility Testing Service Market Share by Country (2021–2032)
Figure 44. Mexico Hemocompatibility Testing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Brazil Hemocompatibility Testing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Middle East & Africa Hemocompatibility Testing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Middle East & Africa Hemocompatibility Testing Service Market Share by Country (2021–2032)
Figure 48. Israel Hemocompatibility Testing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Saudi Arabia Hemocompatibility Testing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. UAE Hemocompatibility Testing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 51. Matexcel Revenue Growth Rate in Hemocompatibility Testing Service Business (2021–2026)
Figure 52. Eurofins Revenue Growth Rate in Hemocompatibility Testing Service Business (2021–2026)
Figure 53. Nelson Laboratories, LLC Revenue Growth Rate in Hemocompatibility Testing Service Business (2021–2026)
Figure 54. Haemoscan Revenue Growth Rate in Hemocompatibility Testing Service Business (2021–2026)
Figure 55. Measurlabs Revenue Growth Rate in Hemocompatibility Testing Service Business (2021–2026)
Figure 56. STEMart Revenue Growth Rate in Hemocompatibility Testing Service Business (2021–2026)
Figure 57. NAMSA Revenue Growth Rate in Hemocompatibility Testing Service Business (2021–2026)
Figure 58. Lupine Medical Revenue Growth Rate in Hemocompatibility Testing Service Business (2021–2026)
Figure 59. Eurolab Revenue Growth Rate in Hemocompatibility Testing Service Business (2021–2026)
Figure 60. Nucro-Technics Revenue Growth Rate in Hemocompatibility Testing Service Business (2021–2026)
Figure 61. TÜV SÜD Revenue Growth Rate in Hemocompatibility Testing Service Business (2021–2026)
Figure 62. Eucerep Revenue Growth Rate in Hemocompatibility Testing Service Business (2021–2026)
Figure 63. UL Solutions Revenue Growth Rate in Hemocompatibility Testing Service Business (2021–2026)
Figure 64. Level Biotechnology Inc. Revenue Growth Rate in Hemocompatibility Testing Service Business (2021–2026)
Figure 65. Cosmos Biomed Consulting Revenue Growth Rate in Hemocompatibility Testing Service Business (2021–2026)
Figure 66. Charles River Laboratories Revenue Growth Rate in Hemocompatibility Testing Service Business (2021–2026)
Figure 67. Ceshigo Revenue Growth Rate in Hemocompatibility Testing Service Business (2021–2026)
Figure 68. Kerbio Revenue Growth Rate in Hemocompatibility Testing Service Business (2021–2026)
Figure 69. Weike Inspection Group Revenue Growth Rate in Hemocompatibility Testing Service Business (2021–2026)
Figure 70. CTI Revenue Growth Rate in Hemocompatibility Testing Service Business (2021–2026)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
den_biaoTiZhungShi

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Hemocompatibility Testing Service in 2032?zhanKai
The global market size of Hemocompatibility Testing Service in 2032 was 148 Million USD.
Which region is expected to have the highest market share?shouQi
What is the annual compound growth rate of the global Hemocompatibility Testing Service market size from 2026 to 2032?shouQi
Which companies rank high in the global Hemocompatibility Testing Service market?shouQi
What was the global market size of Hemocompatibility Testing Service in 2026?shouQi
den_biaoTiZhungShi

Related Reports

Global Hemocompatibility Testing Service Market Research Report 2026

Industry: Service & Software

Published Date: 2026-03-09

Pages: 129 Pages

Report ld: 6079550

CHOOSE LICENSE TYPE
tip

USD 2900.00

tip

USD 4350.00

tip

USD 5800.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

English,Chinese

Offline

HITESH

English, Hindi

Online

TANG XIN

Japanese,English

Offline

SUNG-BIN YOON

SUNG-BIN YOON

+82-2883 1278

Korean, English

Offline

YUJIE TIAN

Chinese, English

Offline

DAMON

Chinese, English

Offline

General Email:

REPORT COVERAGE

den_ic8

DESCRIPTION

zhankai
den_ic7

OVERVIEW

den_ic7

MARKET SEGMENTATION

den_ic7

CHAPTER OUTLINE

den_ic7

QYRESEARCH'S STRENGTHS

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

INTEREST IN THIS REPORT?

yangBenGet A Free Sample

baoJia Request For Quotation

OR

NEED A CUSTOMIZED REPORT?

DingZhiCustomized Report

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now